ALX Oncology Inc.

NASDAQ: ALXO · Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 15, 2025, 3:59 PM
0.64
0.59%
After-hours: Aug 15, 2025, 05:02 PM EDT

ALX Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-25.95M -30.75M -29.16M -30.71M -39.4M -35.58M -45.47M -50.99M -34.16M -30.18M -30.71M -35.32M -32.92M -24.53M -28.44M -24.57M -16.27M -14.19M
Depreciation & Amortization
191K 211K 214K 224K 220K 214K 207K 209K 207K 213K 105K 95K 84K 58K 34K 6K 6K 5K
Stock-Based Compensation
2.14M 5.22M 5.86M 6.95M 7.25M 7.03M 6.72M 6.96M 6.24M 6.35M 6.29M 6.21M 5.84M 5.5M 5.69M 4.19M 2.24M 1.8M
Other Working Capital
-4.14M 1.2M -4.98M -1.13M 4.33M -6.23M 4.82M 5.24M 3M -1.77M 1.52M 1.26K 6.25M -3.68M 596K -2.56M -5.19M -159K
Other Non-Cash Items
3.39M 19K -195K -523K -849K -1.03M 10.15M 372K 368K -748K -332K 302K 192K 425K 4.96M 256K 146K 58K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -11.62M -1.84M -1.65M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-3.17M 645K -8.76M -1.32M 6.21M -8.56M 331K 14.13M -2.71M -3.45M 3.97M -1.81M 9.81M -2.13M 266K -4.74M -6.74M 7.19M
Operating Cash Flow
-23.41M -24.66M -32.05M -25.38M -26.57M -37.92M -39.68M -31.16M -31.71M -27.82M -20.67M -30.88M -17M -20.67M -17.49M -24.86M -20.62M -5.13M
Capital Expenditures
-47K -60K -60K -149K -90K -148K -148K 1.3M -1.74M -690K -389K -192K -257K -589K -4.52M -398K n/a -7K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 50.94K n/a -7.95K -42.98K -11.33K n/a 75.88K n/a n/a n/a n/a n/a
Purchase of Investments
-25.4M -15.78M -4.44M -8.71M -62.96M -31.29M -75.01M -52.89M -46.53M -72.2M -60.97M -36.61M -95.88M -183.33M n/a n/a n/a n/a
Sales Maturities Of Investments
47.77M 43.48M 37.69M 34.55M 63.96M 57.91M 58.49M 64.4M 54.48M 115.19M 72.3M 50.5M 20M n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -50.94K n/a 7.95K 42.98K 11.33K 13.89K -75.88K -183.33K -4.26M n/a n/a n/a
Investing Cash Flow
22.32M 27.64M 33.18M 25.69M 907K 26.47M -16.67M 12.81M 6.21M 42.3M 10.94M 13.7M -76.13M -183.92M -4.52M -398K n/a -7K
Debt Repayment
-237K -307K -76K -358K -218K -175K -63K -111K -107K -107K 9.24M -141K -35K -105K -104K -104K n/a n/a
Common Stock Repurchased
15K n/a n/a n/a n/a n/a n/a n/a n/a n/a 336K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 29.71M 534K 1.17M 237K n/a n/a 450K n/a n/a 5K 457K 185K 628K 543K 731K 778K
Financial Cash Flow
-222K 65K 328K 251K 27.15M 3.09M 59.17M -111K 343K -107K 9.49M -136K 422K 80K 524K 439K 731K 778K
Net Cash Flow
-1.31M 3.05M 1.47M 568K 1.49M -8.37M 2.82M -18.45M -25.16M 14.37M -232K -17.32M -92.71M -204.51M -21.48M -24.82M -19.89M -4.36M
Free Cash Flow
-23.45M -24.72M -32.11M -25.52M -26.66M -38.07M -39.83M -29.86M -33.45M -28.51M -21.06M -31.07M -17.25M -21.26M -22.01M -25.25M -20.62M -5.14M